Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Anebulo Pharmaceuticals, Inc. ANEB |
Nantahala Capital Management, LLC | 3,547,398 8.630% |
3,547,398![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Apyx Medical Corporation APYX |
Nantahala Capital Management, LLC | 3,493,235 9.990% |
3,493,235![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | BlackSky Technology Inc. BKSY |
Nantahala Capital Management, LLC | 1,377,060 4.470% |
-1,072,940![]() (-43.79%) |
Filing History |
2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management, LLC | 2,507,125 5.730% |
-1,170,614![]() (-31.83%) |
Filing History |
2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | CONNS INC CONNQ |
Nantahala Capital Management, LLC | 1,389,773 5.580% |
-874,805![]() (-38.63%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | DarioHealth Corp. DRIO |
Nantahala Capital Management, LLC | 3,512,946 9.990% |
458,014![]() (+14.99%) |
Filing History |
2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Establishment Labs Holdings Inc. ESTA |
Nantahala Capital Management, LLC | 1,682,688 6.100% |
-676,453![]() (-28.67%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Eventbrite, Inc. EB |
Nantahala Capital Management, LLC | 5,930,947 7.300% |
5,930,947![]() (New Position) |
Filing History |
2025-02-03 4:47 pm Purchase |
2025-02-03 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 254,639 15.990% |
7![]() (+0.00%) |
Filing History |
2024-12-20 4:32 pm Purchase |
2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management, LLC | 10,879,142 9.990% |
719,793![]() (+7.09%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO |
Nantahala Capital Management, LLC | 4,426,382 9.990% |
1,926,601![]() (+77.07%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | CONNS INC CONNQ |
Nantahala Capital Management, LLC | 2,264,578 9.100% |
2,264,578![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | DarioHealth Corp. DRIO |
Nantahala Capital Management, LLC | 3,054,932 9.990% |
293,792![]() (+10.64%) |
Filing History |
2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | DHI Group, Inc. DHX |
Nantahala Capital Management, LLC | 2,376,606 4.910% |
-263,081![]() (-9.97%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Elutia Inc. ELUT |
Nantahala Capital Management, LLC | 2,983,568 9.990% |
1,070,792![]() (+55.98%) |
Filing History |
2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | enVVeno Medical Corporation NVNO |
Nantahala Capital Management, LLC | 1,285,857 7.056% |
-113,731![]() (-8.13%) |
Filing History |
2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | Establishment Labs Holdings Inc. ESTA |
Nantahala Capital Management, LLC | 2,359,141 8.543% |
-111,013![]() (-4.49%) |
Filing History |
2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | Evolus, Inc. EOLS |
Nantahala Capital Management, LLC | 2,824,849 4.477% |
-86,000![]() (-2.95%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC |
Nantahala Capital Management, LLC | 4,777,912 7.657% |
4,777,912![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Aprea Therapeutics, Inc. APRE |
Nantahala Capital Management, LLC | 411,520 7.300% |
411,520![]() (New Position) |
Filing History |